COVID-19 outcomes in patients with hematologic disease
- PMID: 32376969
- PMCID: PMC7201203
- DOI: 10.1038/s41409-020-0931-4
COVID-19 outcomes in patients with hematologic disease
Conflict of interest statement
MM reports grants and/or lecture honoraria from Janssen, Sanofi, Maat Pharma, JAZZ pharmaceutical, Celgene, Amgen, BMS, Takeda, Pfizer, and Roche, all outside the submitted work. FM reports lecture honoraria from Therakos/Mallinckrodt, Biocodex, Janssen, Keocyt, Sanofi, JAZZ pharmaceutical and Astellas, all outside the submitted work. RD reports lecture honoraria from Keocyt, Sanofi, and Novartis, all outside the submitted work. The other authors declare no competing financial interests.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical